AOD 9604 Peptide 10MG

AOD 9604 Peptide: The Premier Research Compound for Lipolysis and Metabolic Studies

In the realm of metabolic and body composition research, scientists are continually searching for compounds that can isolate specific physiological pathways without triggering unwanted systemic effects. The AOD 9604 peptide has emerged as a highly significant compound in this pursuit, offering researchers a targeted tool for studying fat metabolism and cellular energy utilization.

At BioApex Express, we provide the highest purity AOD-9604 peptide available for advanced in-vitro laboratory research and tissue analysis protocols. This comprehensive guide explores the science behind this specialized peptide fragment, its mechanisms of action, potential benefits in research models, and how it is utilized in controlled laboratory settings.

What is AOD 9604?

AOD 9604 (Anti-Obesity Drug 9604) is a synthetic peptide fragment. Specifically, it is a modified version of the C-terminal region of human growth hormone (HGH), comprising amino acids 177 through 191.

To understand AOD-9604, one must understand the parent hormone. Full-length human growth hormone is responsible for a wide array of physiological processes, including cellular growth, insulin regulation, and fat metabolism (lipolysis). Researchers discovered that the fat-burning properties of HGH were localized almost entirely within the C-terminal end of the molecule.

By isolating and synthesizing just this specific fragment (amino acids 177-191) and adding a tyrosine amino acid to stabilize it, researchers created the AOD9604 peptide. This allowed them to study the lipolytic (fat-burning) effects of growth hormone without triggering the cellular growth (hyperplasia) or insulin resistance often associated with full-length HGH administration.

What Does the AOD-9604 Peptide Do?

In laboratory and preclinical models, the primary function of the AOD 9604 peptide is to act as a potent stimulator of lipolysis and an inhibitor of lipogenesis.

Researchers study AOD9604 to observe its effects on:

• Lipolysis and Fat Metabolism: Understanding how the peptide stimulates the breakdown of stored triglycerides into free fatty acids.
• Lipogenesis Inhibition: Investigating its ability to prevent the formation of new fat cells from dietary lipids.
• Metabolic Signaling Pathways: Observing how it interacts with beta-3 adrenergic receptors to increase energy expenditure.
• Body Composition Research: Studying its effects on visceral and subcutaneous adipose tissue in various animal models.
• Cartilage and Joint Repair: Emerging research is also exploring its potential role in cartilage regeneration and osteoarthritis models, often in conjunction with other peptides.

How Does AOD 9604 Work? (Mechanism of Action)

The mechanism of action for AOD-9604 is highly targeted toward adipose (fat) tissue, making it a fascinating subject for metabolic research.

1. Stimulation of Lipolysis: AOD-9604 mimics the way natural growth hormone regulates fat metabolism. It binds to specific receptors on the surface of fat cells (adipocytes). This binding triggers an intracellular cascade that activates hormone-sensitive lipase (HSL), the enzyme responsible for breaking down stored triglycerides into free fatty acids and glycerol, which can then be used by the body for energy.
2. Inhibition of Lipogenesis: Simultaneously, research indicates that AOD-9604 inhibits the activity of acetyl-CoA carboxylase, a key enzyme involved in the synthesis of new fatty acids. By blocking this pathway, the peptide helps prevent the storage of new fat.
3. Beta-3 Adrenergic Receptor Interaction: Some studies suggest that AOD-9604 may upregulate beta-3 adrenergic receptors, which are heavily involved in thermogenesis (heat production) and the burning of brown adipose tissue.

Crucially, because it is only a fragment of HGH, AOD-9604 does not bind to the primary growth hormone receptors responsible for IGF-1 production. Therefore, it does not induce cellular growth or negatively impact blood sugar levels.

AOD 9604 Benefits 

Based on extensive preclinical studies and laboratory observations, the potential benefits of AOD-9604 are significant, particularly in models of obesity and metabolic syndrome. Researchers investigating the AOD 9604 peptide frequently focus on the following observed outcomes:

• Targeted Fat Reduction: In animal models, AOD-9604 has consistently demonstrated the ability to reduce body fat, particularly stubborn visceral fat, without affecting lean muscle mass.
• Improved Lipid Profiles: Research models often show a reduction in circulating triglycerides and improvements in overall lipid metabolism following administration.
• No Effect on Blood Sugar: Unlike full-length HGH, which can induce insulin resistance and elevate blood glucose, AOD-9604 has been shown to have no adverse effects on carbohydrate metabolism or insulin sensitivity.
• Potential for Cartilage Repair: Recent studies have begun exploring AOD-9604 intra-articularly (injected into the joint) for its potential to stimulate proteoglycan and collagen production in cartilage tissue models.

AOD 9604 Dosage 

Disclaimer: The following information is based on standard laboratory research protocols and preclinical animal models. AOD-9604 is a research compound not approved for human consumption. Dosages are provided for educational and research design purposes only.

In research settings, the dosage of AOD9604 is typically calibrated based on the subject model’s weight and the specific metabolic pathways being investigated.

• Standard Systemic Research Dosage: A common dosage range observed in literature for metabolic and lipolytic research is 250 to 500 micrograms (mcg) administered once or twice daily.
• Administration Timing: Because the goal is often to study the mobilization of free fatty acids for energy, researchers frequently administer the peptide to models in a fasted state (e.g., morning) to maximize the lipolytic response without interference from dietary insulin.

AOD 9604 Half-Life

Understanding the pharmacokinetics of the compound is crucial for designing effective research protocols.

• Systemic Half-Life: The systemic half-life of injectable AOD-9604 is relatively short, estimated to be in the range of 30 to 60 minutes.
• Implications for Research: Despite the short half-life in the bloodstream, the downstream lipolytic effects (the activation of hormone-sensitive lipase) are sustained for several hours. Research protocols frequently utilize once or twice-daily dosing to maintain a consistent metabolic shift throughout the study period.

How to Use AOD 9604 

Researchers utilizing the AOD-9604 peptide employ strict laboratory protocols to ensure compound stability and accurate dosing.

1. Reconstitution: The product arrives as a lyophilized (freeze-dried) powder in a 10mg vial. It must be reconstituted using sterile bacteriostatic water. The volume of water added determines the concentration of the resulting solution.
2. Administration: The reconstituted solution is administered via subcutaneous injection (just under the skin) using an insulin syringe. This method provides the highest bioavailability for systemic distribution to adipose tissue.
3. Storage: Unreconstituted vials should be stored in a cool, dark environment (or frozen for long-term storage). Once reconstituted with bacteriostatic water, the vial must be kept refrigerated (2–8°C) to maintain peptide stability.

AOD 9604 Side Effects

In extensive animal models and preclinical trials, AOD-9604 has demonstrated an exceptionally high safety profile. Because it isolates the lipolytic function of HGH while discarding the growth-promoting functions, it avoids the most severe side effects associated with growth hormone therapy.

Researchers have noted a distinct lack of severe adverse reactions or toxicity in study models. Potential mild side effects observed are typically related to the administration method or the metabolic shift, such as:

• Mild redness or irritation at the injection site (if administered subcutaneously).
• Temporary, mild flushing or feeling of warmth.
• Mild lethargy or headache in some models.

Crucially, researchers do not observe the insulin resistance, joint pain, or unwanted tissue growth that can occur with full-length HGH administration.

Note: Long-term human clinical trials are lacking, and the full spectrum of potential side effects in humans is not definitively established.

Where to Buy AOD 9604 Peptide

When conducting sensitive metabolic and body composition research, the purity of your compounds is paramount. Contaminants or degraded peptides can alter metabolic responses, invalidating your data.

If you are looking to source the highest quality research materials, BioApex Express is the premier destination for the AOD9604 peptide.

The BioApex Express Advantage:

• 99.8%+ Purity Guarantee: Our AOD-9604 (10mg) is rigorously tested via third-party High-Performance Liquid Chromatography (HPLC) to ensure maximum purity and batch consistency.
• Transparent Lab Results: We provide accessible Certificates of Analysis (COAs) so you can research with absolute confidence.
• Fast, Secure Shipping: We offer same-day dispatch and secure, encrypted checkout, ensuring your research materials arrive promptly and safely.
• Dedicated Support: Our team is ready to assist your laboratory with any procurement needs.

Elevate your metabolic research with the industry standard in peptide purity.

[Buy Premium AOD-9604 (10mg) Now]

Disclaimer: AOD-9604 (10mg) is sold strictly for laboratory research use only. It is not for human consumption, veterinary use, or therapeutic application. Purchasers must be qualified professionals familiar with the handling of research chemicals.